glp 1 agonist fda approval Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the Adverse Event Reporting System database | BMC Medicine FDA approves first generic GLP-1

In rodents, the arrhythmic feeding is featured by hyperphagia during light period (LP), and its correction ameliorates obesity 3,4

References 1 MalikVSWilletWCHuFB

The pattern of association reflected that of the main intention-to-treat analysis, with point estimates less than 1.0 in the as-treated analyses with a one year lag and with increased hazard ratios in the as-treated analyses restricted to the first year after starting treatment

It is great to have new tools added to our toolbox to deal with obesity, she told Healthline

Patient out-of-pocket costs of USD 200 to USD 500 monthly drive the 68% GLP-1 drug discontinuation rate in real-world adherence studies within the first 12 months of therapy

12 Other users describe an initial good result that then plateaus off relatively quickly